A case is presented of a 10-year-old girl with refractory leukemia with poor prognosis and chemotherapy-induced heart failure. She is evaluated for a ventricular assist device (VAD), but the pediatric heart failure team views VAD as clinically inappropriate due to her active oncologic problems. This article examines ethical concerns that arise in deciding whether to offer and use this technology.
CITATION STYLE
Patel, A., Joong, A., Lelkes, E., & Gossett, J. G. (2019). Should physicians offer a ventricular assist device to a pediatric oncology patient with a poor prognosis? AMA Journal of Ethics, 21(5), E380–E386. https://doi.org/10.1001/amajethics.2019.380
Mendeley helps you to discover research relevant for your work.